Last Updated on February 14, 2023
Strategic Plan sets ambitions for us to achieve our strategic objectives that contribute towards ensuring availability of quality assured, safe and effective Therapeutic Goods (TGs) in Pakistan. We are committed to maximize opportunities of treatment for patients for the people of Pakistan.
Our Strategic planning is based our vision of enhancing Access to Medicine for all by contributing to advancement in the health care regulations in Pakistan
Strategic Plan 2022-2025
The Strategic Planning of DRAP for the Year 2022-2025 is focused on following four areas where prioritized activities are identified under each strategic goal.
Goal 1: Optimized Regulatory System
-> Strengthening of Pharmacovigilance
-> Monitoring of Antimicrobial Consumption (AMC)
-> International Accreditations
-> Effective regulation of therapeutic goods
Goal 2: Better Informed Users
-> Safe and Rational use of therapeutic goods
-> Prompt communication with public
-> Improve public awareness
-> Involvement of all stakeholders
Goal 3: Access to Health Products by All
-> Addressing shortages
-> Early access to new treatments
-> Integrity of supply chain
-> MRPs regulation
Goal 4: Strengthening Internal Capabilities
-> Capacity building
-> Automation of Quality Management System (QMS)
-> Financial self-sufficiency
-> Strengthening infrastructure
Here is the complete Strategic Plan 2022-2025
DRAP’s Core Values
Evidence based Decision Making
Collaboration and Harmonization
Regulatory Reliance
Continuous Improvement
Transparency and Visibility
Automation
“IIt is the first time that DRAP has outlined its strategic plan based on the necessary improvements that regulatory framework requires at this time. This document will allow us to move quickly towards establishing an agile regulatory system to protect the citizens of Pakistan from spurious and sub-standard therapeutic goods”
Asim Rauf, CEO DRAP
